DICE Fail-to-Deliver

DICE Therapeutics, Inc. (DICE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.27B, listed on NASDAQ, employing roughly 71 people, carrying a beta of 0.00 to the broader market. DICE Therapeutics, Inc. Led by J. Kevin Judice, public since 2021-09-15.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-09-14

Latest FTD Quantity

453

Latest Price

$24.83

30-Day Avg FTD

4.9K

30-Day Total FTD

146.1K

Showing 30 days of SEC fail-to-deliver data for DICE Therapeutics, Inc..

Learn how fails-to-deliver is reported and how to read the data →